[26] [27] This dual mechanism has produced greater weight loss in clinical studies (SURMOUNT programme) compared with GLP-1 agonists alone, and tirzepatide received MHRA approval for weight management in the UK
Adverse effects include flatulence, oily spotting, and fecal urgency and incontinence
D-psicose increases energy expenditure and decreases body fat accumulation in rats fed a high-sucrose diet
GLP-1 drugs have been linked to everything from weight loss to a lower risk of developing cardiovascular disease, with new benefits coming out all the time
Probiotics are generally safe but immunocompromised patients and those with central venous catheters require caution
Every batch undergoes rigorous testing for potency, purity, sterility, and endotoxins